Grufity logoGrufity logo

MDT

79.62USD+0.37(+0.47%)Market Closed

Medtronic PLC

Market Summary

USD79.62+0.37Market Closed
0.47%

MDT Alerts

MDT Stock Price

RSI Chart

Valuation

Market Cap

115.4B

Price/Earnings

22.17

Price/Sales

3.71

Price/Cashflow

16.17

MarketCap/EBT

20.15

Price/Sales

Profitability

EBT Margin

18.44%

Return on Equity

9.85%

Return on Assets

5.79%

Fundamentals

Revenue

Revenue (TTM)

30.8B

Revenue Y/Y

-3.34%

Revenue Q/Q

2.9%

Earnings

Earnings (TTM)

4.3B

Earnings Y/Y

-67.43%

Earnings Q/Q

-54.04%

Price Action

52 Week Range

75.83113.44
(Low)(High)

Last 7 days

0.6%

Last 30 days

-7.2%

Last 90 days

-8.7%

Trailing 12 Months

-24.3%

Financial Health

Current Ratio

1.58

Debt/Equity

0.38

Debt/Cashflow

0.36

Investor Care

Dividend Yield

2.98%

Dividend/Share (TTM)

2.65

Buy Backs (1Y)

1.07%

Diluted EPS (TTM)

3.22

Peers (Alternatives to Medtronic)

View All Peers In Detail
NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
115.4B
30.8B
-7.18% -24.29%
22.17
3.71
-3.11% -8.14%
86.3B
6.1B
15.30% -16.82%
62.6
14.1
11.47% -18.42%
43.9B
5.4B
8.87% -30.30%
30.09
8.18
5.29% -1.25%
16.7B
4.9B
3.03% 3.70%
11.05
3.2
-13.66% -30.36%
14.7B
3.9B
10.79% -68.25%
23.8
3.69
2.88% -30.98%
MID-CAP
6.4B
806.4M
33.98% -14.84%
-331.15
7.96
20.10% -221.96%
5.4B
2.5B
4.03% -10.74%
21.1
2.14
-7.05% -15.83%
2.5B
1.0B
15.54% -32.32%
-91.07
2.5
-1.73% 77.34%
2.4B
1.1B
19.80% -33.11%
-29.5
2.28
7.99% -232.91%
SMALL-CAP
1.4B
153.2M
25.78% 10.08%
-19.11
9.54
29.47% -132.69%
1.4B
71.8M
38.68% 184.47%
-28.63
26.58
154.25% -11.51%
1.0B
795.9M
17.05% -10.97%
-131.34
1.33
8.11% 182.50%
994.0M
154.8M
-8.78% -40.92%
-10.57
6.72
60.29% -2309.58%
516.6M
353.3M
7.68% -26.19%
-18.21
1.46
4.89% -1057.51%
86.7M
510.5M
-19.96% -81.26%
-0.87
0.16
-26.64% -46.15%

Financials for Medtronic

Income Statement (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Revenue-0.8%30,80831,07031,68631,78531,797
  S&GA Expenses0.0%10,31410,31210,29210,31810,294
Earnings Before Taxes-1.7%5,6305,7285,5175,4815,112
Net Income-17.0%4,3215,2055,0394,9144,704
Balance Sheet
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Assets3.7%93,24189,91490,98191,80491,756
  Current Assets14.7%25,39822,13523,05923,30322,731
    Cash Equivalents125.6%4,8282,1403,7143,4792,900
  Inventory5.1%5,0554,8094,6164,5144,349
  Net PPE0.3%5,2985,2815,4135,2515,188
  Goodwill0.2%40,41740,32440,50241,34641,612
Liabilities11.1%41,18437,07138,26039,09139,596
  Current Liabilities3.0%14,46514,04912,3948,9277,803
  Long Term Debt5.0%21,10020,10022,90026,50028,000
Shareholder's Equity-1.5%52,05752,84352,55152,54251,991
  Retained Earnings-1.6%29,79930,27630,25029,60728,974
  Additional Paid-In Capital0.4%24,44224,33524,56625,81426,059
Accumulated Depreciation0.4%7,8237,790---
Shares Outstanding0.1%1,3301,3291,3311,3431,345
Minority Interest4.1%177170171171168
Float-161,200----
* denotes actual numbers (not divided by Millions)
Cashflow (Last 12 Months)
(In Millions)
Description(%) Q/Q2022Q42022Q32022Q22022Q12021Q4
Cashflow From Operations-11.9%6,2907,1377,3467,0347,162
  Share Based Compensation-0.9%349352359356343
Cashflow From Investing-17.8%-2,897.00-2,460.00-1,659.00-11.00-2,347.00
Cashflow From Financing79.7%-1,062.00-5,231.00-5,336.00-8,516.00-8,337.00
  Dividend Payments1.9%3,3833,3213,255
  Buy Backs-8.8%2,2552,4722,5441,6201,257

Risks

What is the probability of a big loss on MDT?

40%


Probability that Medtronic stock will be more than 20% underwater in next one year

26.5%


Probability that Medtronic stock will be more than 30% underwater in next one year.

0%


Probability that Medtronic stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does MDT drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Medtronic was unfortunately bought at previous high price.

Returns

Cumulative Returns on MDT

8.9%


10-Year Cumulative Returns

2.4%


7-Year Cumulative Returns

1.7%


5-Year Cumulative Returns

-8.6%


3-Year Cumulative Returns

What are the long-term rolling returns for MDT?

FIve years rolling returns for Medtronic.

Which funds bought or sold MDT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2022-11-29
Bridgefront Capital, LLC
SOLD OFF
-100
-494,000
-
-%
2022-11-23
FSB PREMIER WEALTH MANAGEMENT, INC.
REDUCED
-14.04
-110,000
373,000
0.22%
2022-11-23
Gould Capital, LLC
SOLD OFF
-
-
-
-%
2022-11-23
Eagle Bay Advisors LLC
REDUCED
-45.06
-90,847
90,000
0.06%
2022-11-23
Toroso Investments, LLC
REDUCED
-5.87
-898,000
4,967,000
0.21%
2022-11-22
CONTINENTAL INVESTORS SERVICES, INC.
NEW
-
397,000
397,000
0.01%
2022-11-22
B. Riley Wealth Advisors, Inc.
ADDED
6.25
-124,000
2,696,000
0.08%
2022-11-22
CVA Family Office, LLC
ADDED
71.94
248,000
702,000
0.19%
2022-11-22
IHT Wealth Management, LLC
ADDED
21.48
59,000
689,000
0.05%
2022-11-22
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
NEW
-
10,225,000
10,225,000
0.12%

1–10 of 46

Latest Funds Activity

Are funds buying MDT calls or puts?
Are funds bullish or bearish(Calls - Puts)?
No. of funds that own MDT

Medtronic News

Seeking Alpha

2 Urgent Dividend Sells & 2 Blue Chip Replacements To Increase Your Income.28 hours ago

MDT Fair Value

Recent SEC filings of Medtronic

View All Filings
Date Filed Form Type Document
Nov 22, 2022
8-K
Current Report
Oct 25, 2022
11-K
Employee Benefit Details
Oct 25, 2022
11-K
Employee Benefit Details
Oct 17, 2022
4
Insider Trading
Sep 21, 2022
8-A12B
8-A12B
Sep 21, 2022
8-K
Current Report
Sep 21, 2022
CERT
CERT
Sep 16, 2022
424B5
Prospectus Filed
Sep 15, 2022
424B3
Prospectus Filed
Sep 15, 2022
FWP
Prospectus Filed

Latest Insider Trading transactions for MDT

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2022-10-14
TEN HOEDT ROB
SOLD
-196,015
81.537
-2,404
EVP and Pres. Global Regions
2022-10-14
TEN HOEDT ROB
ACQUIRED
100,006
41.6
2,404
EVP and Pres. Global Regions
2022-08-01
WHITE ROBERT JOHN
ACQUIRED
-
-
8,595
EVP & Pres. Medical Surgical
2022-08-01
Smith Gregory L
ACQUIRED
-
-
5,587
EVP Global Ops & Supply Chain
2022-08-01
Martha Geoffrey
ACQUIRED
-
-
28,471
Chairman and CEO
2022-08-01
Surface Carol A
ACQUIRED
-
-
5,157
EVP, Chief HR Officer
2022-08-01
Salmon Sean
ACQUIRED
-
-
8,595
EVP & President Cardiovascular
2022-08-01
Wall Brett A.
ACQUIRED
-
-
7,521
EVP & Pres Neuroscience
2022-08-01
Fong Ivan K
ACQUIRED
-
-
6,941
EVP GENERAL COUNSEL & SECR
2022-08-01
TEN HOEDT ROB
ACQUIRED
-
-
7,306
EVP & President EMEA

1–10 of 50

Geoffrey S. Martha
65535
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.